Wedge Capital Management L L P NC increased its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 4.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 209,190 shares of the medical technology company’s stock after buying an additional 8,095 shares during the period. Wedge Capital Management L L P NC’s holdings in Hill-Rom were worth $17,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the company. Citigroup Inc. increased its stake in Hill-Rom by 21.1% in the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after buying an additional 433 shares during the period. DekaBank Deutsche Girozentrale increased its stake in Hill-Rom by 101.0% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,720 shares of the medical technology company’s stock valued at $204,000 after buying an additional 1,367 shares during the period. Fox Run Management L.L.C. acquired a new position in Hill-Rom in the 3rd quarter valued at $207,000. CAPROCK Group Inc. acquired a new position in shares of Hill-Rom during the 4th quarter worth $211,000. Finally, Braun Stacey Associates Inc. acquired a new position in shares of Hill-Rom during the 4th quarter worth $233,000. 81.34% of the stock is currently owned by institutional investors and hedge funds.

HRC has been the topic of a number of recent analyst reports. KeyCorp reaffirmed a “buy” rating and set a $82.00 price target on shares of Hill-Rom in a research note on Tuesday, October 17th. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a research note on Friday, October 27th. ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. Needham & Company LLC lowered their price target on shares of Hill-Rom from $93.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, November 6th. Finally, Stifel Nicolaus upped their price target on shares of Hill-Rom from $84.00 to $85.00 and gave the stock a “buy” rating in a research note on Monday, November 6th. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $95.38.

Shares of Hill-Rom Holdings, Inc. (NYSE HRC) opened at $87.03 on Monday. Hill-Rom Holdings, Inc. has a 1 year low of $59.32 and a 1 year high of $91.11. The company has a quick ratio of 1.29, a current ratio of 1.75 and a debt-to-equity ratio of 1.39. The company has a market cap of $5,759.10, a PE ratio of 29.60, a P/E/G ratio of 1.45 and a beta of 1.05.

Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Friday, January 26th. The medical technology company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.79 by $0.13. Hill-Rom had a net margin of 7.14% and a return on equity of 20.24%. The business had revenue of $669.70 million for the quarter, compared to analyst estimates of $670.00 million. During the same period in the previous year, the firm earned $0.75 EPS. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. analysts anticipate that Hill-Rom Holdings, Inc. will post 4.62 earnings per share for the current fiscal year.

In other Hill-Rom news, CEO John J. Greisch sold 125,241 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $82.59, for a total value of $10,343,654.19. Following the transaction, the chief executive officer now directly owns 280,851 shares in the company, valued at approximately $23,195,484.09. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Paul Sherwood Johnson sold 1,000 shares of the company’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $82.99, for a total transaction of $82,990.00. Following the completion of the transaction, the senior vice president now owns 1,066 shares in the company, valued at $88,467.34. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 226,241 shares of company stock worth $18,708,644. 1.90% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Wedge Capital Management L L P NC Acquires 8,095 Shares of Hill-Rom Holdings, Inc. (HRC)” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/wedge-capital-management-l-l-p-nc-acquires-8095-shares-of-hill-rom-holdings-inc-hrc/1845802.html.

About Hill-Rom

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.